Transient Ischemic Attack clinical trials at UC Irvine

1 research study open to eligible people

Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
open to eligible people ages 40 years and up
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Irvine, California and other locations

Last updated: December 4, 2025